ImmunoGen, Inc. Quarterly Depreciation, Depletion and Amortization in USD from Q3 2010 to Q1 2023
-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
The aggregate expense recognized in the current period that allocates the cost of tangible assets, intangible assets, or depleting assets to periods that benefit from use of the assets.
-
Summary
-
ImmunoGen, Inc. quarterly/annual Depreciation, Depletion and Amortization history and growth rate from Q3 2010 to Q1 2023.
- ImmunoGen, Inc. Depreciation, Depletion and Amortization for the quarter ending March 31, 2023 was $448K, a 5.29% decline year-over-year.
- ImmunoGen, Inc. annual Depreciation, Depletion and Amortization for 2022 was $1.78M, a 11.6% decline from 2021.
- ImmunoGen, Inc. annual Depreciation, Depletion and Amortization for 2021 was $2.02M, a 4% decline from 2020.
- ImmunoGen, Inc. annual Depreciation, Depletion and Amortization for 2020 was $2.1M, a 47.8% decline from 2019.
Depreciation, Depletion and Amortization, Quarterly (USD)
Depreciation, Depletion and Amortization, YoY Quarterly Growth (%)